S0768 restricts the use of certain software in Florida laboratories and adds ownership-disclosure protections for licensed entities. In the laboratory section, the bill bars the Department of Health from allowing any laboratory under s. 381.0202 to use operational or research software for genetic sequencing if the software is produced in, by, or through a foreign country of concern, a state-owned enterprise of such a country, or a company domiciled there. The bill defines “foreign country of concern” to include China, Russia, Iran, North Korea, Cuba, the Maduro regime in Venezuela, and Syria.
The bill also amends Florida’s minimum licensure requirements in s. 408.810 to address indirect ownership interests tied to foreign countries of concern. A licensee must ensure that a person or entity with a controlling interest does not directly or indirectly hold an interest in an entity that has a business relationship with a foreign country of concern or is subject to Florida’s anti-foreign-influence restrictions. At the same time, the bill provides that a licensee’s failure to obtain assurances from an indirect interest holder will not by itself affect licensure or insurability, or create civil or criminal liability, unless the licensee actually knows the indirect holder is a foreign principal from a foreign country of concern and is not compliant with the statute.
Impact
The bill changes Florida law by adding a new restriction on laboratory software used for genetic sequencing and by tightening, while also clarifying, licensure compliance rules for entities with ownership ties that may involve foreign countries of concern. It affects laboratories regulated under s. 381.0202 and licensed providers under s. 408.810, particularly those with complex ownership structures, private equity involvement, or indirect investors. The measure also cross-references Florida’s existing foreign-influence and public-contracting restrictions, and it takes effect July 1, 2025.
Sentiment
The bill appears to have been broadly supported and moved through both chambers with overwhelming approval. It passed Senate committees with only one dissenting vote in Health Policy and then received unanimous support in Judiciary, Rules, and on final Senate readings, as well as near-unanimous House approval on third reading. The voting pattern suggests strong bipartisan agreement on the bill’s national-security and foreign-influence rationale.
Contention
The main policy concern appears to be the extent to which Florida should restrict technology and ownership links associated with foreign countries of concern, especially in sensitive areas like genetic sequencing and health care licensing. The bill’s laboratory software ban may raise operational and procurement concerns for labs that rely on widely used software or vendors with international supply chains, while the licensure provisions could be seen as imposing compliance burdens on providers with layered ownership structures. However, the recorded votes show little public contention in the Legislature, with the only notable opposition occurring in the initial Senate Health Policy committee vote.
Property: recording; marketable record title act; revise. Amends title & secs. 1, 1a, 2, 3, 4, 5, 6 & 8 of 1945 PA 200 (MCL 565.101 et seq.) & adds sec. 5a.